Table 1.

Patient characteristics, N = 44

Characteristic	No.	%
Median age, y (range)	64 (49-86)
Sex
Female	14	32
Male	30	68
No. of prior treatments, median (range)	5 (1-15)
Fludarabine refractory	12	27
Rai stage
I to II	24	55
III to IV	20	45
Serum β2M, median (range)	4.3 (1.6-10.1)
Bulky adenopathies	17	39
VH mutation status
Mutated	4	9
Unmutated	29	66
Not tested	11	25
FISH
13q−	5	11
+12	6	14
Normal	7	16
11q−	18	41
17p−	8	18